Published in J Mol Cell Cardiol on May 01, 1975
Anoxic contractile failure in rat heart myocytes is caused by failure of intracellular calcium release due to alteration of the action potential. Proc Natl Acad Sci U S A (1988) 1.47
The role of calcium in the ischemic myocardium. Am J Pathol (1981) 1.41
Oxygen-induced enzyme release after irreversible myocardial injury. Effects of cyanide in perfused rat hearts. Am J Pathol (1976) 1.28
The effects of glucose, acetate, lactate and insulin on protein degradation in the perfused rat heart. Biochem J (1982) 1.26
Cell surface changes and enzyme release during hypoxia and reoxygenation in the isolated, perfused rat liver. J Cell Biol (1983) 1.13
Effects of anoxic or oxygenated reperfusion in globally ischemic, isovolumic, perfused rat hearts. Am J Pathol (1985) 0.96
Uncoupling of increased cellular oxidative stress and myocardial ischemia reperfusion injury by directed sarcolemma stabilization. J Mol Cell Cardiol (2013) 0.95
Reperfusion-induced injury: a possible role for oxidant stress and its manipulation. Cardiovasc Drugs Ther (1991) 0.90
Anoxia induces time-independent K+ current through KATP channels in isolated heart cells of the guinea-pig. J Physiol (1992) 0.89
Ultrastructural changes in the myocardial myocytic mitochondria: crucial step in the development of oxygen radical-induced damage in isolated rat hearts? Basic Res Cardiol (1994) 0.81
Is thrombolysis alone the best therapy for acute myocardial infarction? Current status and emerging strategies. Tex Heart Inst J (1991) 0.76
Role of a nonsteroidal anti-inflammatory agent, ibuprofen, in coronary revascularization after acute myocardial infarction. Basic Res Cardiol (1990) 0.75
The NLM Indexing Initiative. Proc AMIA Symp (2000) 11.40
Knowledge-based indexing of the medical literature: the Indexing Aid Project. J Am Soc Inf Sci (1987) 4.15
The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion. Cardiovasc Res (1988) 3.98
Myocardial ischaemia: can we agree on a definition for the 21st century? Cardiovasc Res (1994) 2.16
Third generation calcium entry blockers. Blood Press (1996) 2.12
Reperfusion-induced arrhythmias: mechanisms and prevention. J Mol Cell Cardiol (1984) 2.00
The oxygen paradox and the calcium paradox: two facets of the same problem? J Mol Cell Cardiol (1978) 1.95
Hypoxia and calcium. J Mol Cell Cardiol (1979) 1.94
A protective effect of verapamil on hypoxic heart muscle. Cardiovasc Res (1976) 1.91
Species variation in the coronary collateral circulation during regional myocardial ischaemia: a critical determinant of the rate of evolution and extent of myocardial infarction. Cardiovasc Res (1987) 1.83
Abrupt reoxygenation of the anoxic potassium-arrested perfused rat heart: a study of myocardial enzyme release. J Mol Cell Cardiol (1973) 1.77
Direct detection of free radicals in the reperfused rat heart using electron spin resonance spectroscopy. Circ Res (1987) 1.74
Reperfusion of the ischemic myocardium. J Mol Cell Cardiol (1977) 1.74
Formation of 4-hydroxy-2-nonenal-modified proteins in ischemic rat heart. Am J Physiol (1999) 1.61
Ischemic contracture of the myocardium: mechanisms and prevention. Am J Cardiol (1977) 1.61
Irreversible myocardial injury in anoxic perfused rat hearts. Am J Pathol (1975) 1.60
Calcium antagonists. Eur Heart J (1980) 1.58
Protective effect of pretreatment with verapamil, nifedipine and propranolol on mitochondrial function in the ischemic and reperfused myocardium. Am J Cardiol (1980) 1.54
Reperfusion-induced arrhythmias and oxygen-derived free radicals. Studies with "anti-free radical" interventions and a free radical-generating system in the isolated perfused rat heart. Circ Res (1986) 1.52
The influence of some physico-chemical factors on the biliary excretion of a series of structurally related aryl sulphate esters. Biochem Pharmacol (1969) 1.51
The gut origin septic states in blunt multiple trauma (ISS = 40) in the ICU. Ann Surg (1987) 1.50
Oxygen deprivation and early myocardial contractile failure: a reassessment of the possible role of adenosine triphosphate. Am J Cardiol (1979) 1.48
The antiarrhythmic action of ischaemic preconditioning in rat hearts does not involve functional Gi proteins. Cardiovasc Res (1993) 1.46
Optimal myocardial protection during crystalloid cardioplegia. Interrelationship between volume and duration of infusion. J Thorac Cardiovasc Surg (1988) 1.43
Protection of the immature myocardium during global ischemia. A comparison of four clinical cardioplegic solutions in the rabbit heart. J Thorac Cardiovasc Surg (1989) 1.43
The role of calcium in the ischemic myocardium. Am J Pathol (1981) 1.41
Cardiogenic shock secondary to mitral stenosis treated by balloon mitral valvuloplasty. Cathet Cardiovasc Diagn (1998) 1.40
Ischemia and reperfusion-induced arrhythmias in the rat. Effects of xanthine oxidase inhibition with allopurinol. Circ Res (1984) 1.39
Harvesting hearts for long-term preservation. Detrimental effects of initial hypothermic infusion of cardioplegic solutions. J Thorac Cardiovasc Surg (1990) 1.38
Preconditioning of ischemic myocardium: reperfusion-induced arrhythmias. Am J Physiol (1987) 1.35
The isolated blood and perfusion fluid perfused heart. Pharmacol Res (2000) 1.34
Discriminant effectiveness of psychological state measures in predicting performance outcome in karate competition. Percept Mot Skills (1995) 1.29
Calcium entry in the calcium paradox. J Mol Cell Cardiol (1981) 1.29
Calcium antagonists: a new class of drugs. Pharmacol Ther (1983) 1.28
Effect of propranolol, a beta-adrenergic antagonist, on blood flow in the coronary and other vascular fields. Am Heart J (1967) 1.28
Xanthine oxidase: a critical mediator of myocardial injury during ischemia and reperfusion? Acta Physiol Scand Suppl (1986) 1.26
Hypothermic arrest and potassium arrest: metabolic and myocardial protection during elective cardiac arrest. Circ Res (1975) 1.25
Ischaemia-induced and reperfusion-induced arrhythmias differ in their sensitivity to potassium: implications for mechanisms of initiation and maintenance of ventricular fibrillation. J Mol Cell Cardiol (1989) 1.23
The role of glucose in the survival and 'recovery' of the anoxic isolated perfused rat heart. Biochem J (1972) 1.20
Effect of verapamil on contractility, oxygen utilization, and calcium exchangeability in mammalian heart muscle. Cardiovasc Res (1972) 1.18
Verapamil and the myocardium. Postgrad Med J (1974) 1.18
Stability and change in mothers' representations of their relationship with their toddlers. Dev Psychol (1999) 1.16
The negative inotropic effect of adrenergic betareceptor blocking drugs on human heart muscle. Cardiovasc Res (1969) 1.15
The "border zone" in evolving myocardial infarction: controversy or confusion? Am J Cardiol (1981) 1.14
The effect of beta-adrenoceptor and Ca2+ antagonist drugs on the hypoxia-induced increased in resting tension. Cardiovasc Res (1978) 1.13
An effect of ouabain on the superficially-located stores of calcium in cardiac muscle cells. J Mol Cell Cardiol (1973) 1.13
Coronary vascular responsiveness to 5-hydroxytryptamine before and after infusion of hyperkalemic crystalloid cardioplegic solution in the rat heart. Possible evidence of endothelial damage. J Thorac Cardiovasc Surg (1989) 1.13
Multiple N-acetyltransferases and drug metabolism. Tissue distribution, characterization and significance of mammalian N-acetyltransferase. Biochem J (1973) 1.12
Creatine kinase isoenzymes: their separation and quantitation. Cardiovasc Res (1977) 1.12
Calcium, sodium, and the calcium paradox. Circ Res (1984) 1.10
Effect of methylprednisolone sodium succinate on hypoxic heart muscle. Cardiovasc Res (1976) 1.09
Myocardial protection during ischemic cardiac arrest. A possible hazard with calcium-free cardioplegic infusates. J Thorac Cardiovasc Surg (1977) 1.09
Improved functional recovery by ischaemic preconditioning is not mediated by adenosine in the globally ischaemic isolated rat heart. Cardiovasc Res (1993) 1.08
Free radicals and reperfusion-induced arrhythmias: protection by spin trap agent PBN in the rat heart. Circ Res (1987) 1.08
Some effects of the hypotensive drug diazoxide on the cardiovascular system. Am Heart J (1968) 1.08
Regulation of sarcolemmal Na(+)/H(+) exchanger activity by angiotensin II in adult rat ventricular myocytes: opposing actions via AT(1) versus AT(2) receptors. Circ Res (1999) 1.07
The effect of beta adrenergic antagonists on cardiac contractions, myofibrillar ATPase activity, high-energy phosphate stores and lipid-facilitated transfort of calciumiones. J Pharmacol Exp Ther (1969) 1.05
Reperfusion-induced arrhythmias are critically dependent upon occluded zone size: relevance to the mechanism of arrhythmogenesis. J Mol Cell Cardiol (1989) 1.04
Some effects of iproveratril (Isoptin) on the cardiovascular system. J Pharmacol Exp Ther (1968) 1.04
Pharmacological protection of mitochondrial function in hypoxic heart muscle: Effect of verapamil, propranolol, and methylprednisolone. Cardiovasc Res (1978) 1.03
Cellular protection during myocardial ischemia: the development and characterization of a procedure for the induction of reversible ischemic arrest. Circulation (1976) 1.03
A longitudinal study of maternal involvement and symbolic play during the toddler period. Child Dev (1987) 1.03
Effect of alpha-tocopherol on hypoxic-perfused and reoxygenated rabbit heart muscle. J Mol Cell Cardiol (1978) 1.03
The relationship of ischemic contracture of vascular reperfusion in the isolated rat heart. J Mol Cell Cardiol (1980) 1.02
Enzyme release during myocardial anoxia: a study of metabolic protection. J Mol Cell Cardiol (1975) 1.01
The failure of endothelin to displace bound, radioactively-labelled, calcium antagonists (PN 200/110, D888 and diltiazem). Br J Pharmacol (1989) 1.00
Ischemia-induced and reperfusion-induced arrhythmias: importance of heart rate. Am J Physiol (1989) 1.00
Calcium exchange in cardiac muscle: a basic mechanism of drug action. Am Heart J (1967) 1.00
Concentration of catecholamines in human cardiac muscle. Br Heart J (1979) 0.99
Effect of caffeine on calcium in subcellular fractions of cardiac muscle. Am J Physiol (1966) 0.99
Recovery from cardiac bypass and elective cardiac arrest. The metabolic consequences of various cardioplegic procedures in the isolated rat heart. Circ Res (1974) 0.99
The calcium paradox: metabolic, electrophysiological, contractile and ultrastructural characteristics in four species. Eur J Cardiol (1978) 0.99
Cold cardioplegia or continuous coronary perfusion? Report on preliminary clinical experience as assessed cytochemically. J Thorac Cardiovasc Surg (1977) 0.98
The interaction of calcium antagonists (slow channel blockers) with myocardial alpha adrenoceptors. J Mol Cell Cardiol (1982) 0.98
Myocardial protection during ischemic cardiac arrest. The importance of magnesium in cardioplegic infusates. J Thorac Cardiovasc Surg (1978) 0.97
Contracture and the calcium paradox. J Mol Cell Cardiol (1985) 0.97
Temporal and spatial characteristics of evolving cell injury during regional myocardial ischemia in the dog: the "border zone" controversy. J Am Coll Cardiol (1983) 0.96
Effects of anoxic or oxygenated reperfusion in globally ischemic, isovolumic, perfused rat hearts. Am J Pathol (1985) 0.96
Chemical modification of serine at the active site of penicillin acylase from Kluyvera citrophila. Biochem J (1991) 0.96
Brain death-induced impairment of cardiac contractile performance can be reversed by explantation and may not preclude the use of hearts for transplantation. Circ Res (1992) 0.96
Effect of o-2-hydroxy-3-(tert.-butylamino) propoxybenzonitrile HCl (KO 1366) on beta adrenergic receptors in the cardiovascular system. J Pharmacol Exp Ther (1972) 0.95
Uptake of catecholamines by human cardiac muscle in vitro. Br Heart J (1979) 0.95
Effect of isoproterenol on contractions and phosphorylase activity of normo- and hypothermic cardiac muscle. Arch Int Pharmacodyn Ther (1967) 0.95
Sustained limitation of myocardial necrosis 24 hours after coronary artery occlusion: verapamil infusion in dogs with small myocardial infarcts. Am J Cardiol (1983) 0.94
Xanthine oxidase is not a source of free radicals in the ischemic rabbit heart. J Mol Cell Cardiol (1987) 0.94
Diabetes and the survival and recovery of the anoxic myocardium. J Mol Cell Cardiol (1975) 0.94
Developments in cardioprotection: "polarized" arrest as an alternative to "depolarized" arrest. Ann Thorac Surg (1999) 0.94
Beta-adrenoceptor antagonists and the release of creatine phosphokinase from hypoxic heart muscle. Cardiovasc Res (1977) 0.94
Calcium and cell death. Eur Heart J (1983) 0.94
The metabolic fate and elimination of streptozotocin. Biochem Soc Trans (1975) 0.94
"Dose"-dependency and temporal characteristics of protection by ischaemic preconditioning against ischaemia-induced arrhythmias in rat hearts. J Mol Cell Cardiol (1993) 0.93
Verapamil and the calcium paradox. J Mol Cell Cardiol (1980) 0.93
Effect of inotropic agents on canine trabecular muscle rendered highly permeable to calcium. Am J Physiol (1973) 0.93